Do you want to read an article? Please log in or register.
Pre-treatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients with Inflammatory Bowel Diseases
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Short Disease Duration Is Associated With Increased Risk of Treatment Failure in Biologic-Treated Patients With Ulcerative Colitis
Inflamm Bowel Dis.
Nguyen NH, Kurnool S, Dulai PS, Boland BS, Sandborn WJ, Singh S
doi: 10.1093/ibd/izz276.
Inflammatory Bowel Disease
Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients with Inflammatory Bowel Diseases: a Systematic Review and Meta-analysis
Clin Gastroenterol Hepatol.
Singh S, Facciorusso A, Dulai PS, Jairath V, Sandborn WJ
doi: 10.1016/j.cgh.2019.02.044.
Inflammatory Bowel Disease
Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines
United European Gastroenterol J.
Wisniewski A, Kirchgesner J, Saint-Antoine IBD network.
doi: 10.1177/2050640619889763.
RECOMMENDED
Inflammatory Bowel Disease
No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases
doi: 10.1053/j.gastro.2018.11.067.
Inflammatory Bowel Disease
Risk of bacteremia in hospitalised patients with inflammatory bowel disease: a 9-year cohort study
United European Gastroenterol J.
Goren I, Brom A, Yanai H, Dagan A, Segal G, Israel A
doi: 10.1177/2050640619874524.
Inflammatory Bowel Disease
Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy
Inflamm Bowel Dis.
Chen C, Hartzema AG, Xiao H, Wei YJ, Chaudhry N, Ewelukwa O, Glover SC, Zimmermann EM
doi: 10.1093/ibd/izz001.
Inflammatory Bowel Disease
Mortality Associated With Development of Squamous Cell Cancer in Patients With Inflammatory Bowel Disease Receiving Treatment With Thiopurines
Clin Gastroenterol Hepatol.
Khan N, Lee H, Trivedi C, Kavani H, Medvedeva E, Xie D, Lewis JD, Yang YX
doi: 10.1016/j.cgh.2019.03.005.
Inflammatory Bowel Disease
Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)
Eur J Clin Microbiol Infect Dis.
Vehreschild MJGT, Taori S, Goldenberg SD, Thalhammer F, Bouza E, van Oene J, Wetherill G, Georgopali A
doi: 10.1007/s10096-018-3344-1.
COMMENTED
Inflammatory Bowel Disease
Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
★ 3
Recommended and commented by
PD Dr Luc Biedermann, Faculty Member
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Gastroenterology.
Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD
doi: 10.1053/j.gastro.2020.05.032.